The U.S. Preventative Services Task Force (USPSTF) released updated recommendations for BRCA1/2 testing, suggesting practitioners increase the use of genetic counseling and testing.

Synthesized digital mammography (SM) was created to help reduce the radiation dose for patients undergoing digital mammography (DM) in digital breast tomosynthesis (DBT), so why haven’t more clinics adopted it?

After looking at more than 12,500 preventative office visits included in the National Ambulatory Medical Care Survey, researchers reported that the rate of screening breast ultrasound ordering by physicians has remained low.

CMS revealed details for their newly proposed alternative payment model for radiation oncology on July 10. The American Society of Radiation Oncology (ASTRO) believes the model, with adjustments, "will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure."

Breast cancer screening using digital breast tomosynthesis has risen rapidly in the United States, but that isn’t the case in all regions or across all institutions, according to a new study published in Current Problems in Diagnostic Radiology.

Although most studies demonstrating the benefits of digital breast tomosynthesis (DBT) have been observational, use of the modality has risen dramatically over the past few years, according to a study of more than nine million women published in JAMA Internal Medicine.

Proponents of risk-based mammography screening claim the method successfully emphasizes its benefits and minimizes its harms, but new research has found it may not be as effective as age-based screening.

Combining MRI and ultrasound (US) detected up to 33% more cancers than standard biopsy methods alone, according to new research published in JAMA Surgery.